James Thomson
About James Thomson
James Thomson is the Senior Director of Worldwide Oncology Commercial Strategy, Performance & Forecasting at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
James Thomson currently serves as the Senior Director of Worldwide Oncology Commercial Strategy, Performance & Forecasting at Bristol Myers Squibb. In this role, he leads a cross-geography team responsible for the commercial strategy and performance management for a global oncology portfolio exceeding $10 billion. His responsibilities also include supporting investor relations messaging and early asset strategy prioritization.
Previous Experience at Bristol Myers Squibb
James Thomson has an extensive history with Bristol Myers Squibb, having held multiple roles over the years. From 2020 to 2021, he served as the Director of Worldwide Oncology Forecasting & Strategic Planning. Between 2018 and 2020, he was the Director of U.S. Hematology & Oncology Customer Insights & Market Research in Lawrenceville, NJ. Prior to this, from 2016 to 2018, he worked as the Associate Director of U.S. Oncology Commercial Insights & Analytics in Plainsboro, NJ. He also held roles as Senior Product Manager for U.S. ELIQUIS Hospital & IDN Marketing Preceptorship, and as Associate Director of U.S. Cardiovascular Commercial Insights & Analytics between 2014 and 2016.
Early Career and Different Industries
James Thomson began his career as an Actuarial Analyst with Willis Towers Watson, where he worked from 2005 to 2007. He also had a stint as an Actuarial Summer Intern in 2004. He gained experience in financial reporting and executive compensation at PepsiCo between 2007 and 2008. Additionally, he worked at ZS Associates as a Consultant, and later as Manager, focusing on healthcare industry analytics and consulting. His roles at ZS Associates took place from 2010 to 2014 in Princeton, NJ.
Education and Expertise
James Thomson holds a BS in Biometry & Statistics with a Pre-Med emphasis from Cornell University. He furthered his education by obtaining an MBA with a focus on Business Administration and Management from the University of Virginia - Darden Graduate School of Business Administration. His expertise spans across targeting and segmentation within the healthcare industry, finance, analytics, business development, and life cycle management of oncology products.